A discussion is presented on the main NGS sequencing technologies that can be used to improve the diagnosis, prognosis, and treatment of oncology patients.
Next-generation sequencing (NGS) has revolutionized diagnostic pathology by offering more extensive and rapid
genomic examination compared to traditional approaches. This review assesses the recent developments in NGS and
their use in the diagnosis of diseases. The results based on secondary data illustrate advances in...
S. Pawar· International Journal of Dru...· 0 citations
Precision medicine (also known as individualized or personalized medicine) is a novel approach that integrates genetic, environmental, and lifestyle data to drive medical care decisions. It aims to give more precise approaches to illness prevention, diagnosis, and treatment.(1) In oncology, precision medicine is based...
Ariba Asif· International journal of pat...· 0 citations
The uses and applications of molecular profiling technologies such as next-generation sequencing, liquid biopsies, and multi-omics in the process of profiling cancer tumors and their associated molecular changes are discussed.
Imran khan Yousafzai, Khadija Tariq, Noor Fatima et al.· Journal of Cancer Biomolecul...· 0 citations
The biological rationale rooted in the genomic basis of cancer and the concept of oncogene addiction is outlined, and the enabling technologies - next-generation sequencing, comprehensive genomic profiling, large reference atlases, and liquid biopsy - are described that have made molecular characterization feasible in...
Mohd Faizan Siddiqui· International Research Journ...· 0 citations
The continued integration of genomics, AI-driven diagnostics, biomarker-guided therapies, and multidisciplinary clinical approaches is anticipated to improve patient outcomes while promoting precision oncology as the new standard of cancer care.
Ulykbek Daurenov, Dastan Turdykul, Dana Suyunbay et al.· International Scientific Uni...· 0 citations
These clinical practice guidelines are provided to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice.
Nuria Rodriguez Salas, J. R. De la Haba-Rodríguez, Ferran Ferragut Lloret et al.· Clinical and Translational O...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.